Publications by Dr Amy Anderson - ePrints

Browsing publications by Dr Amy Anderson.

Newcastle Authors	Title	Year
Philip Brown Dr Amy Anderson Najib Naamane Dr Dennis Lendrem Professor John Isaacs et al.	Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritis	2024
Dr Abi Gault Dr Linda Hogarth Dr Kristian Williams Professor Alastair Greystoke Professor Neil Rajan et al.	Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study	2024
Dr Ken Baker Dr David McDonald Dr Gill Hulme Raf Hussain Dr Jonathan Coxhead et al.	Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission	2024
Professor Catharien Hilkens Julie Diboll Dr Fiona Cooke Dr Amy Anderson	In vitro generation of human tolerogenic monocyte-derived dendritic cells	2023
Gemma Vidal Pedrola Najib Naamane Dr Arthur Pratt Emeritus Professor Andrew Mellor Professor John Isaacs et al.	Characterization of age-associated B cells in early drug-naïve rheumatoid arthritis patients	2023
Dr Kristian Williams Abigail Gault Dr Amy Anderson Professor Christopher Stewart Professor Chris Lamb et al.	Immune-related adverse events in checkpoint blockade: Observations from human tissue and therapeutic considerations	2023
Dr Fiona Cooke Dr Mary Neal Dr Matthew Wood Dr Amy Anderson Julie Diboll et al.	Fluorine labelling of therapeutic human tolerogenic dendritic cells for 19F-magnetic resonance imaging	2022
Dr Faye Cooles Dr Jessica Tarn Dr Dennis Lendrem Najib Naamane Alice Lin et al.	Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming	2022
Professor John Isaacs Sarah Brockbank Dr Ayako Pedersen Professor Catharien Hilkens Dr Amy Anderson et al.	RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients	2022
Dr Fiona Rayner Dr Amy Anderson Dr Ken Baker Professor Christopher Buckley Dr Bernard Dyke et al.	BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort study	2021
Dr Nicola Maney Dr Ben Barron-Millar Dr Christopher Carey Ian Herron Dr Amy Anderson et al.	Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis	2021
Alex Clark Dr Amy Anderson Dr Nishanthi Thalayasingam Najib Naamane Julie Diboll et al.	Lymphocyte DNA methylation mediates genetic risk at shared immune-mediated disease loci	2020
Dr Amy Anderson Dr Nicola Maney Dr Dennis Lendrem Julie Diboll Dr Philip Brown et al.	Expression of STAT3-regulated genes in circulating CD4+ T cells discriminates rheumatoid arthritis independently of clinical parameters in early arthritis	2019
Laura Ridgley Dr Amy Anderson Dr Nicola Maney Najib Naamane Andrew Skelton et al.	IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function	2019
Dr Rachel Spiering Matthew Wood Anshor Fath Oliver Eltherington Dr Amy Anderson et al.	Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis	2019
Dr Nishanthi Thalayasingam Andrew Skelton Dr Amy Anderson Alex Clark Julie Diboll et al.	CD4+ and B lymphocyte expression quantitative traits at rheumatoid arthritis risk loci in untreated early arthritis: implications for causal gene identification	2018
Dr Faye Cooles Dr Amy Anderson Andrew Skelton Dr Arthur Pratt Professor Iain McInnes et al.	Phenotypic and transcriptomic analysis of peripheral blood plasmacytoid and conventional dendritic cells in early drug naïve rheumatoid arthritis	2018
Laura Ridgley Dr Amy Anderson Dr Arthur Pratt	What are the dominant cytokines in early rheumatoid arthritis?	2018
Dr Gillian Bell Dr Amy Anderson Julie Diboll Oliver Eltherington Dr Rachel Harry et al.	Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis	2017
Dr Amy Anderson	Increased Expression of Cytotoxic T-Lymphocyte−Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure	2017
Dr Faye Cooles Dr Amy Anderson Dr Dennis Lendrem Julie Norris Dr Arthur Pratt et al.	The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy	2017
Dr Amy Anderson Dr David Swan Oliver Eltherington Dr Arthur Pratt Dr Gary Reynolds et al.	Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4⁺ T-cells partly via TGF-β1	2017
Dr Arthur Pratt Dr Amy Anderson Professor John Isaacs	Bcl-3 in CD4+ T Cell–Mediated Rheumatoid Arthritis Pathogenesis: Comment on the Article by Meguro et al	2016
Dr Arthur Pratt Dr Amy Anderson Professor John Isaacs Julie Diboll Dr Nishanthi Thalayasingam et al.	Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23	2016
Dr Arthur Pratt Dr Amy Anderson Julie Diboll Andrew Skelton Dr Dennis Lendrem et al.	Identification of novel expression quantitative trait loci in CD4+ T cells of untreated early arthritis patients	2016
Dr Amy Anderson Dr Arthur Pratt Dr John Doran Christine Routledge Ben Hargreaves et al.	IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anti-citrullinated peptide antibody-negative rheumatoid arthritis	2016
Dr Faye Cooles Dr Amy Anderson Dr Rachel Harry Julie Diboll Lee Munro et al.	Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies	2016
Dr Phillip Lord Dr Rachel Spiering Dr Amy Anderson Julie Diboll Emeritus Professor Lindsay Marshall et al.	Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies	2016
Dr Amy Anderson	Adaptive Immune Reponses in ALF	2015
Dr Amy Anderson Dr Carmen Martin-Ruiz Professor Dawn Teare	RIPOSTE: a framework for improving the design and analysis of laboratory-based research	2015
Dr Arthur Pratt Dr Amy Anderson Dr Dennis Lendrem Julie Diboll Ben Hargreaves et al.	STAT3-regulated gene expression in circulating CD4+ T cells discriminates RA patients independently of clinical parameters in early arthritis: a validation study.	2015
Dr Arthur Pratt Dr Amy Anderson Julie Diboll Andrew Skelton Ben Hargreaves et al.	The Importance of IL-6-STAT₃ Mediated Activation of Circulating CD4⁺ T Cells in the Pathogenesis of Early Seronegative Rheumatoid Arthritis: A Validation Study	2015
Dr Faye Cooles Dr Amy Anderson Professor Catharien Hilkens Professor John Isaacs	The Interferon Gene Signature in Early Rheumatoid Arthritis Demonstrates No Significant Association with Disease Activity	2015
Harriet Purvis Dr Amy Anderson Professor David Young Professor John Isaacs Professor Catharien Hilkens et al.	A Negative Feedback Loop Mediated by STAT3 Limits Human Th17 Responses	2014
Marilena Patsalidou Dr Amy Anderson Dr Anja Krippner-Heidenreich	An unconventional anti-inflammatory role for TNF recpetor (TNFR)1 in tregs: TNFR1 and 2 differetnialy modulate FOXP3+ TREG function	2014
Dr Gillian Bell Dr Amy Anderson Julie Diboll Dr Rachel Harry Emerita Professor Elaine McColl et al.	Autologous Tolerogenic Dendritic Cells for Rheumatoid and Inflammatory Arthritis.	2014
Dr Gillian Bell Dr Amy Anderson Dr Rachel Harry Julie Diboll Emerita Professor Elaine McColl et al.	Autologous tolerogenic dendritic cells in rheumatoid and inflammatory arthritis	2014
Dr Amy Anderson Christine Routledge Professor John Isaacs Dr Arthur Pratt	Investigation of interleukin-6-driven STAT3 signalling in circulating lymphocytes of patients with early rheumatoid arthritis as a route to biomarker discovery	2014
Dr Amy Anderson Dr Arthur Pratt Ben Hargreaves Philip Brown Professor John Isaacs et al.	Phospho-STAT1/3 and Gene Expression Measurement in Circulating CD4⁺ T Cells As Diagnostic Tools in Early Autoantibody-Negative Rheumatoid Arthritis	2014
Dr Amy Anderson Dr Arthur Pratt Ben Hargreaves Philip Brown Professor John Isaacs et al.	Phospho-STAT1/3 measurement in circulating CD4+T-cells as a diagnostic tool in early autoantibody-negative rheumatoid arthritis	2014
Dr Gillian Bell Dr Amy Anderson Julie Diboll Dr Rachel Harry Emerita Professor Elaine McColl et al.	Autologous Tolerogenic Dendritic Cells In Rheumatoid and Inflammatory Arthritis	2013
Dr Amy Anderson Christine Routledge Phil Mawson Professor John Isaacs Dr Arthur Pratt et al.	Interleukin-6 driven STAT3 phosphorylation in circulating lymphocytes is specific for CD4 T cells in early rheumatoid arthritis	2013
Dr Amy Anderson Christine Routledge Phil Mawson Professor John Isaacs Dr Arthur Pratt et al.	Interleukin-6 Driven STAT3 Phosphorylation In Circulating Lymphocytes Is Specific For CD4⁺ T Cells In Early Rheumatoid Arthritis	2013
Dr Faye Cooles Professor John Isaacs Dr Amy Anderson	Treg Cells in Rheumatoid Arthritis: An Update	2013
Dr Gillian Bell Dr Amy Anderson Dr Rachel Harry Dr Jeroen Stoop Professor Catharien Hilkens et al.	Autologous tolerogenic dendritic cells in rheumatoid arthritis	2012
Harriet Purvis Dr Amy Anderson Professor Catharien Hilkens	Human T helper 17 responses: the effect of T-cell density	2012
Dr Amy Anderson Dr Alice Lorenzi Dr Arthur Pratt Thomas Wooldridge Julie Diboll et al.	Immunity 12 years after alemtuzumab in RA: CD5+ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses	2012
Harriet Purvis Dr Amy Anderson Professor Catharien Hilkens	Human Th17 responses: the effect of T-cell density	2011
Dr Malcolm Brodlie Dr Michael McKean Dr Amy Anderson Professor Catharien Hilkens Professor Andrew Fisher et al.	Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease	2011
Dr Rachel Harry Dr Amy Anderson Professor John Isaacs Professor Catharien Hilkens	Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis	2010
Harriet Purvis Dr Jeroen Stoop Professor Jelena Mann Steven Woods Anne Kozijn et al.	Low strength T-cell activation promotes Th17 responses	2010
Dr Jeroen Stoop Professor Jelena Mann Steven Woods Anne Kozijn Professor Sophie Hambleton et al.	Low-strength T-cell activation promotes Th17 responses	2010
Dr Amy Anderson Dr David Swan Bethan Sayers Dr Rachel Harry Dr Angela Patterson et al.	LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells	2009
Professor John Isaacs Dr Amy Anderson	Regulatory T cells and autoimmunity	2009
Dr Amy Anderson	Seasonal changes in suppressive capacity of CD4 CD25 T cells from patients with hayfever are allergen-specific and may result in part from expansion of effector T cells among the CD25 population	2009
Dr Alice Lorenzi Dr Amy Anderson Dr Jonathan Catterall Dr Angela Patterson Emerita Professor Helen Foster et al.	Thymic function in juvenile idiopathic arthritis	2009
Dr Rachel Harry Dr Amy Anderson Dr Graham Raftery Professor John Isaacs Professor Catharien Hilkens et al.	Development of clinical-grade tolerogenic dendritic cells for the treatment of rheumatoid arthritis	2008
Dr Amy Anderson Bethan Sayers Professor Muzlifah Haniffa Dr David Swan Julie Diboll et al.	Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells	2008
Dr Alice Lorenzi Dr Amy Anderson Dr Jonathan Catterall Dr Angela Patterson Emerita Professor Helen Foster et al.	Thymic function in juvenile idiopathic arthritis	2008
Dr Amy Anderson Bethan Sayers Dr David Swan Professor John Isaacs Professor Catharien Hilkens et al.	Tolerogenic dendritic cell therapy for rheumatoid arthritis	2008
Dr Amy Anderson Professor John Isaacs	Tregs and rheumatoid arthritis	2008
Dr Amy Anderson	TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: Results from a genome-wide scan	2007
Dr Amy Anderson	Helicobacter infection in the surfactant protein D-deficient mouse	2007
Dr Amy Anderson Bethan Sayers Julie Diboll Professor John Isaacs Professor Catharien Hilkens et al.	Tolerogenic dendritic cells differentially modulate naïve and memory CD4⁺ T cells	2007